Regulation of l-Histidine Decarboxylase and Its Role in Carcinogenesis

Progress in Nucleic Acid Research and Molecular Biology

Volumn 81, Issue , 2006, Pages 231-270

  Ai, Wandong ^a   Takaishi, Shigeo ^a   Wang, Timothy C ^a   Fleming, John V ^b  

^a Howard Hughes Medical Institute   (United States)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE DECARBOXYLASE;

ANIMAL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; REVIEW;

ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISTIDINE DECARBOXYLASE; HUMANS; NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 33750611761     PISSN: 00796603     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6603(06)81006-8     Document Type: Review

References (172)

1. Hill S.J., Ganellin C.R., Timmerman H., Schwartz J.C., Shankley N.P., Young J.M., Schunack W., Levi R., and Haas H.L. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol. Rev. 49 (1997) 253-278
2. Coruzzi G., Morini G., Adami M., and Grandi D. Role of histamine H3 receptors in the regulation of gastric functions. J. Physiol. Pharmacol. 52 (2001) 539-553
3. Shiraishi M., Hirasawa N., Kobayashi Y., Oikawa S., Murakami A., and Ohuchi K. Participation of mitogen-activated protein kinase in thapsigargin- and TPA-induced histamine production in murine macrophage RAW 264.7 cells. Br. J. Pharmacol. 129 (2000) 515-524
4. Takamatsu S., Nakashima I., and Nakano K. Modulation of endotoxin-induced histamine synthesis by cytokines in mouse bone marrow-derived macrophages. J. Immunol. 156 (1996) 778-785
5. Shiraishi M., Hirasawa N., Oikawa S., Kobayashi Y., and Ohuchi K. Analysis of histamine-producing cells at the late phase of allergic inflammation in rats. Immunology 99 (2000) 600-606
6. Aoi R., Nakashima I., Kitamura Y., Asai H., and Nakano K. Histamine synthesis by mouse T lymphocytes through induced histidine decarboxylase. Immunology 66 (1989) 219-223
7. Rangachari P.K. Histamine: Mercurial messenger in the gut. Am. J. Physiol. 262 (1992) G1-G13
8. Zhang Z., Hocker M., Koh T.J., and Wang T.C. The human histidine decarboxylase promoter is regulated by gastrin and phorbol 12-myristate 13-acetate through a downstream cis-acting element. J. Biol. Chem. 271 (1996) 14188-14197
9. Hocker M., Henihan R.J., Rosewicz S., Riecken E.O., Zhang Z., Koh T.J., and Wang T.C. Gastrin and phorbol 12-myristate 13-acetate regulate the human histidine decarboxylase promoter through Raf-dependent activation of extracellular signal-regulated kinase-related signaling pathways in gastric cancer cells. J. Biol. Chem. 272 (1997) 27015-27024
10. Hocker M., Zhang Z., Fenstermacher D.A., Tagerud S., Chulak M., Joseph D., and Wang T.C. Rat histidine decarboxylase promoter is regulated by gastrin through a protein kinase C pathway. Am. J. Physiol. 270 (1996) G619-G633
11. Ohgoh M., Yamamoto J., Kawata M., Yamamura I., Fukui T., and Ichikawa A. Enhanced expression of the mouse L-histidine decarboxylase gene with a combination of dexamethasone and 12-O-tetradecanoylphorbol-13-acetate. Biochem. Biophys. Res. Commun. 196 (1993) 1113-1119
12. Hocker M., Rosenberg I., Xavier R., Henihan R.J., Wiedenmann B., Rosewicz S., Podolsky D.K., and Wang T.C. Oxidative stress activates the human histidine decarboxylase promoter in AGS gastric cancer cells. J. Biol. Chem. 273 (1998) 23046-23054
13. Pacilio M., Debili N., Arnould A., Machavoine F., Rolli-Derkinderen M., Bodger M., Arock M., Dumenil D., Dy M., and Schneider E. Thrombopoietin induces histidine decarboxylase gene expression in c-mpl transfected UT7 cells. Biochem. Biophys. Res. Commun. 285 (2001) 1095-1101
14. Wessler S., Hocker M., Fischer W., Wang T.C., Rosewicz S., Haas R., Wiedenmann B., Meyer T.F., and Naumann M. Helicobacter pylori activates the histidine decarboxylase promoter through a mitogen-activated protein kinase pathway independent of pathogenicity island-encoded virulence factors. J. Biol. Chem. 275 (2000) 3629-3636
15. Wessler S., Rapp U.R., Wiedenmann B., Meyer T.F., Schoneberg T., Hocker M., and Naumann M. B-Raf/Rap1 signaling, but not c-Raf-1/Ras, induces the histidine decarboxylase promoter in Helicobacter pylori infection. FASEB J. 16 (2002) 417-419
16. Yamamoto J., Yatsunami K., Ohmori E., Sugimoto Y., Fukui T., Katayama T., and Ichikawa A. cDNA-derived amino acid sequence of L-histidine decarboxylase from mouse mastocytoma P-815 cells. FEBS Lett. 276 (1990) 214-218
17. Yamauchi K., Sato R., Tanno Y., Ohkawara Y., Maeyama K., Watanabe T., Satoh K., Yoshizawa M., Shibahara S., and Takishima T. Nucleotide sequence of the cDNA encoding L-histidine decarboxylase derived from human basophilic leukemia cell line, KU-812-F. Nucleic Acids Res. 18 (1990) 5891
18. Joseph D.R., Sullivan P.M., Wang Y.M., Kozak C., Fenstermacher D.A., Behrendsen M.E., and Zahnow C.A. Characterization and expression of the complementary DNA encoding rat histidine decarboxylase. Proc. Natl. Acad. Sci. USA 87 (1990) 733-737
19. Taguchi Y., Watanabe T., Kubota H., Hayashi H., and Wada H. Purification of histidine decarboxylase from the liver of fetal rats and its immunochemical and immunohistochemical characterization. J. Biol. Chem. 259 (1984) 5214-5221
20. Ohmori E., Fukui T., Imanishi N., Yatsunami K., and Ichikawa A. Purification and characterization of L-histidine decarboxylase from mouse mastocytoma P-815 cells. J. Biochem. (Tokyo) 107 (1990) 834-839
21. Watabe A., Fukui T., Ohmori E., and Ichikawa A. Purification and properties of L-histidine decarboxylase from mouse stomach. Biochem. Pharmacol. 43 (1992) 587-593
22. Fleming J.V., and Wang T.C. Amino- and carboxy-terminal PEST domains mediate gastrin stabilization of rat L-histidine decarboxylase isoforms. Mol. Cell. Biol. 20 (2000) 4932-4947
23. Fleming J.V., and Wang T.C. The production of 53-55-kDa isoforms is not required for rat L-histidine decarboxylase activity. J. Biol. Chem. 278 (2003) 686-694
24. Kahlson G., and Rosengren E. New approaches to the physiology of histamine. Physiol. Rev. 48 (1968) 155-196
25. Tang Z.C., and Xu Y.H. Comparison of the effects of 4-methylhistamine on the cell-cycle response between CFU-s and its subpopulation. Int. J. Cell. Cloning 5 (1987) 511-517
26. Matsuki Y., Tanimoto A., Hamada T., and Sasaguri Y. Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma. Mod. Pathol. 16 (2003) 72-78
27. Tanimoto A., Matsuki Y., Tomita T., Sasaguri T., Shimajiri S., and Sasaguri Y. Histidine decarboxylase expression in pancreatic endocrine cells and related tumors. Pathol. Int. 54 (2004) 408-412
28. Boer K., Darvas Z., Baki M., Kaszas I., Pal Z., and Falus A. Expression of histidine decarboxylase in human colonic cancer cells and adenomatous polyps. Inflamm. Res. 52 Suppl. 1 (2003) S76-S77
29. Darvas Z., Sakurai E., Schwelberger H.G., Hegyesi H., Rivera E., Othsu H., Watanabe T., Pallinger E., and Falus A. Autonomous histamine metabolism in human melanoma cells. Melanoma. Res. 13 (2003) 239-246
30. Modlin I.M., Kumar R.R., Soroka C.J., Ahlman H., Nilsson O., and Goldenring J.R. Histamine as an intermediate growth factor in genesis of gastric ECLomas associated with hypergastrinemia in mastomys. Dig. Dis. Sci. 39 (1994) 1446-1453
31. Takaishi S., Cui G., Frederick D.M., Carlson J.E., Houghton J., Varro A., Dockray G.J., Ge Z., Whary M.T., and Rogers A.B. Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer. Gastroenterology 128 (2005) 1965-1983
32. Suzuki-Ishigaki S., Numayama-Tsuruta K., Kuramasu A., Sakurai E., Makabe Y., Shimura S., Shirato K., Igarashi K., Watanabe T., and Ohtsu H. The mouse L-histidine decarboxylase gene: Structure and transcriptional regulation by CpG methylation in the promoter region. Nucleic Acids Res. 28 (2000) 2627-2633
33. Yatsunami K., Ohtsu H., Tsuchikawa M., Higuchi T., Ishibashi K., Shida A., Shima Y., Nakagawa S., Yamauchi K., and Yamamoto M. Structure of the L-histidine decarboxylase gene. J. Biol. Chem. 269 (1994) 1554-1559
34. Kuramasu A., Saito H., Suzuki S., Watanabe T., and Ohtsu H. Mast cell-/basophil-specific transcriptional regulation of human L-histidine decarboxylase gene by CpG methylation in the promoter region. J. Biol. Chem. 273 (1998) 31607-31614
35. Ai W., Liu Y., Langlois M., and Wang T.C. Kruppel-like factor 4 (KLF4) represses histidine decarboxylase gene expression through an upstream Spl site and downstream gastrin responsive elements. J. Biol. Chem. 279 (2004) 8684-8693
36. Ai W., Liu Y., and Wang T.C. Yin Yang 1 (YY1) represses histidine decarboxylase (HDC) gene expression with SREBP-1a in part through an upstream Spl site. Am. J. Physiol. Gastrointest. Liver Physiol (2005)
37. Raychowdhury R., Fleming J.V., McLaughlin J.T., Bulitta C.J., and Wang T.C. Identification and characterization of a third gastrin response element (GAS-RE3) in the human histidine decarboxylase gene promoter. Biochem. Biophys. Res. Commun. 297 (2002) 1089-1095
38. Raychowdhury R., Zhang Z., Hocker M., and Wang T.C. Activation of human histidine decarboxylase gene promoter activity by gastrin is mediated by two distinct nuclear factors. J. Biol. Chem. 274 (1999) 20961-20969
39. Holliday R. The inheritance of epigenetic defects. Science 238 (1987) 163-170
40. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
41. Xiao H., Chung J., Kao H.Y., and Yang Y.C. Tip60 is a co-repressor for STAT3. J. Biol. Chem. 278 (2003) 11197-11204
42. Fajardo I., Urdiales J.L., Medina M.A., and Sanchez-Jimenez F. Effects of phorbol ester and dexamethasone treatment on histidine decarboxylase and ornithine decarboxylase in basophilic cells. Biochem. Pharmacol. 61 (2001) 1101-1106
43. Kopin A.S., Beinborn M., Lee Y.M., McBride E.W., and Quinn S.M. The CCK-B/gastrin receptor. Identification of amino acids that determine nonpeptide antagonist affinity. Ann. N. Y. Acad. Sci. 713 (1994) 67-78
44. Nilsson O., Kolby L., Wangberg B., Wank S.A., and Ahlman H. Expression of CCK-A and CCK-B/gastrin receptors in enterochromaffin-like cell carcinoids of Mastomys natalensis. Ann. N. Y. Acad. Sci. 713 (1994) 435-438
45. Chen D., Monstein H.J., Nylander A.G., Zhao C.M., Sundler F., and Hakanson R. Acute responses of rat stomach enterochromaffinlike cells to gastrin secretory activation and adaptation. Gastroenterology 107 (1994) 18-27
46. Sandvik A.K., Dimaline R., Marvik R., Brenna E., and Waldum H.L. Gastrin regulates histidine decarboxylase activity and mRNA abundance in rat oxyntic mucosa. Am. J. Physiol. 267 (1994) G254-G258
47. Watanabe T., Taguchi Y., Sasaki K., Tsuyama K., and Kitamura Y. Increase in histidine decarboxylase activity in mouse skin after application of the tumor promoter tetradecanoylphorbol acetate. Biochem. Biophys. Res. Commun. 100 (1981) 427-432
48. Colucci R., Fleming J.V., Xavier R., and Wang T.C. L-histidine decarboxylase decreases its own transcription through downregulation of ERK activity. Am. J. Physiol. Gastrointest. Liver Physiol. 281 (2001) G1081-G1091
49. Ohtsu H., Tanaka S., Terui T., Hori Y., Makabe-Kobayashi Y., Pejler G., Tchougounova E., Hellman L., Gertsenstein M., and Hirasawa N. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett. 502 (2001) 53-56
50. Endo Y., Kikuchi T., Nakamura M., and Shinoda H. Determination of histamine and polyamines in calcified tissues of mice: Contribution of mast cells and histidine decarboxylase to the amount of histamine in the bone. Calcif. Tissue Int. 51 (1992) 67-71
51. Kubo Y., and Nakano K. Regulation of histamine synthesis in mouse CD4+ and CD8+ T lymphocytes. Inflamm. Res. 48 (1999) 149-153
52. Hirasawa N., Murakami A., and Ohuchi K. Expression of 74-kDa histidine decarboxylase protein in a macrophage-like cell line RAW 264.7 and inhibition by dexamethasone. Eur. J. Pharmacol. 418 (2001) 23-28
53. Murata Y., Tanimoto A., Wang K.Y., Tsutsui M., Sasaguri Y., De Corte F., and Matsushita H. Granulocyte macrophage-colony stimulating factor increases the expression of histamine and histamine receptors in monocytes/macrophages in relation to arteriosclerosis. Arterioscler. Thromb. Vase. Biol. 25 (2005) 430-435
54. Galli S.J., Nakae S., and Tsai M. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6 (2005) 135-142
55. Wiener Z., Andrasfalvy M., Pallinger E., Kovacs P., Szalai C., Erdei A., Toth S., Nagy A., and Falus A. Bone marrow-derived mast cell differentiation is strongly reduced in histidine decarboxylase knockout, histamine-free mice. Int. Immunol. 14 (2002) 381-387
56. Ransone L.J., Visvader J., Wamsley P., and Verma I.M. Trans-dominant negative mutants of Fos and Jun. Proc. Natl. Acad. Sci. USA 87 (1990) 3806-3810
57. O'Neill L.A., Dunne A., Edjeback M., Gray P., Jefferies C., and Wietek C. Mal and MyD88: Adapter proteins involved in signal transduction by Toll-like receptors. J. Endotoxin. Res. 9 (2003) 55-59
58. Takeuchi O., and Akira S. Toll-like receptors; their physiological role and signal transduction system. Int. Immunopharmacol. 1 (2001) 625-635
59. Crowe S.E. Helicobacter infection, chronic inflammation, and the development of malignancy. Curr. Opin. Gastroenterol. 21 (2005) 32-38
60. Houghton J., and Wang T.C. Helicobacter pylori and gastric cancer: A new paradigm for inflammation-associated epithelial cancers. Gastroenterology 128 (2005) 1567-1578
61. Farinha P., and Gascoyne R.D. Helicobacter pylori and MALT lymphoma. Gastroenterology 128 (2005) 1579-1605
62. Hocker M., Raychowdhury R., Plath T., Wu H., O'Connor D.T., Wiedenmann B., Rosewicz S., and Wang T.C. Spl and CREB mediate gastrindependent regulation of chromogranin A promoter activity in gastric carcinoma cells. J. Biol. Chem. 273 (1998) 34000-34007
63. Gerhard M., Neumayer N., Presecan-Siedel E., Zanner R., Lengyel E., Cramer T., Hocker M., and Prinz C. Gastrin induces expression and promoter activity of the vesicular monoamine transporter subtype 2. Endocrinology 142 (2001) 3663-3672
64. Zhao C.M., Chen D., Yamada H., Dornonville de la Cour C., Lindstrom E., Persson L., and Hakanson R. Rat stomach ECL cells: Mode of activation of histidine decarboxylase. Regul. Pept. 114 (2003) 21-27
65. Fleming J.V., Fajardo I., Langlois M.R., Sanchez-Jimenez F., and Wang T.C. The C-terminus of rat L-histidine decarboxylase specifically inhibits enzymic activity and disrupts pyridoxal phosphate-dependent interactions with L-histidine substrate analogues. Biochem. J. 381 (2004) 769-778
66. Suzuki S., Tanaka S., Nemoto K., and Ichikawa A. Membrane targeting and binding of the 74-kDa form of mouse L-histidine decarboxylase via its carboxyl-terminal sequence. FEBS Lett. 437 (1998) 44-48
67. Tanaka S., Nemoto K., Yamamura E., and Ichikawa A. Intracellular localization of the 74- and 53-kDa forms of L-histidine decarboxylase in a rat basophilic/mast cell line, RBL-2H3. J. Biol. Chem. 273 (1998) 8177-8182
68. Engel N., Olmo M.T., Coleman C.S., Medina M.A., Pegg A.E., and Sanchez-Jimenez F. Experimental evidence for structure-activity features in common between mammalian histidine decarboxylase and ornithine decarboxylase. Biochem. J. 320 (1996) 365-368
69. Olmo M.T., Urdiales J.L., Pegg A.E., Medina M.A., and Sanchez-Jimenez F. In vitro study of proteolytic degradation of rat histidine decarboxylase. Eur. J. Biochem. 267 (2000) 1527-1531
70. Tanaka S., Nemoto K., Yamamura E., Ohmura S., and Ichikawa A. Degradation of the 74 kDa form of L-histidine decarboxylase via the ubiquitin-proteasome pathway in a rat basophilic/mast cell line (RBL-2H3). FEBS Lett. 417 (1997) 203-207
71. Viguera E., Trelles O., Urdiales J.L., Mates J.M., and Sanchez-Jimenez F. Mammalian L-amino acid decarboxylases producing 1,4-diamines: Analogies among differences. Trends. Biochem. Sci. 19 (1994) 318-319
72. Hammar L., and Hjerten S. Purification and immunochemical analysis of histidine decarboxylase from murine mastocytoma. Agents Actions 10 (1980) 92-93
73. Hammar L. Mammalian histidine decarboxylase: Effect by protein kinase on mouse mastocytoma histidine decarboxylase. Agents Actions 13 (1983) 246-249
74. Taguchi Y., Watanabe T., Kubota H., Hayashi H., and Wada H. Purification of histidine decarboxylase from the liver of fetal rats and its immunochemical and immunohistochemical characterization. J. Biol. Chem. 259 (1984) 5214-5221
75. Tran V., and Snyder S. Histidine decarboxylase. Purification from fetal rat liver, immunologic properties, and histochemical localization in brain and stomach. J. Biol. Chem. 256 (1981) 680-686
76. Martin S.A., and Bishop J.O. Purification and characterization of histidine decarboxylase from mouse kidney. Biochem. J. 234 (1986) 349-354
77. Savany A., and Cronenberger L. Inactivation of rat gastric mucosal histidine decarboxylase by phosphatase. Biochem. Int. 19 (1989) 429-438
78. Savany A., and Cronenberger L. Isolation and properties of multiple forms of histidine decarboxylase from rat gastric mucosa. Biochem. J. 205 (1982) 405-412
79. Huszti Z., Magyar K., and Keleti J. Possible regulation of hypothalamus and lung histidine decarboxylase activity by cAMP-dependent protein kinase. Eur. J. Biochem. 197 (1991) 191-196
80. Yamamoto J., Fukui T., Suzuki K., Tanaka S., Yatsunami K., and Ichikawa A. Expression and characterization of recombinant mouse mastocytoma histidine decarboxylase. Biochim. Biophys. Acta. 1216 (1993) 431-440
81. Dartsch C., Chen D., and Persson L. Multiple forms of rat stomach histidine decarboxylase may reflect posttranslational activation of the enzyme. Regul. Pept. 77 (1998) 33-41
82. Dartsch C., Chen D., Hakanson R., and Persson L. Histidine decarboxylase in rat stomach ECL cells: Relationship between enzyme activity and different molecular forms. Regul. Pept. 81 (1999) 41-48
83. Yatsunami Y., Tsuchikawa M., Kamada M., Hori K., and Higuchi T. Comparative studies of human recombinant 74- and 54-kDa L-histidine decarboxylases. J. Biol. Chem. 270 (1995) 30813-30817
84. Rechsteiner M. PEST sequences are signals for rapid intracellular proteolysis. Semin. Cell Biol. 1 (1990) 433-440
85. Rogers S., Wells R., and Rechsteiner M. Amino acid sequences common to rapidly degraded proteins: The PEST hypothesis. Science 234 (1986) 364-368
86. Rechsteiner M., and Rogers S.W. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21 (1996) 267-271
87. Van Antwerp D.J., and Verma I.M. Signal-induced degradation of I(kappa)B(alpha): Association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required. Mol. Cell Biol. 16 (1996) 6037-6045
88. Loetscher P., Pratt G., and Rechsteiner M. The C terminus of mouse ornithine decarboxylase confers rapid degradation on dihydrofolate reductase. Support for the pest hypothesis. J. Biol. Chem. 266 (1991) 11213-11220
89. Georgescu M.M., Kirsch K.H., Akagi T., Shishido T., and Hanafusa H. The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region. Proc. Natl. Acad. Sci. USA 96 (1999) 10182-10187
90. Georgescu M.M., Kirsch K.H., Kaloudis P., Yang H., Pavletich N.P., and Hanafusa H. Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor. Cancer Res. 60 (2000) 7033-7038
91. Schoonbroodt S., Ferreira V., Best-Belpomme M., Boelaert J.R., Legrand-Poels S., Korner M., and Piette J. Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of I kappa B alpha in NF-kappa B activation by an oxidative stress. J. Immunol. 164 (2000) 4292-4300
92. Alvarez-Castelao B., and Castano J.G. Mechanism of direct degradation of IkappaBalpha by 20S proteasome. FEBS Lett. 579 (2005) 4797-4802
93. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell. 79 (1994) 13-21
94. Tanaka S., Takasu Y., Mikura S., Satoh N., and Ichikawa A. Antigen-independent induction of histamine synthesis by immunoglobulin E in mouse bone marrow-derived mast cells. J. Exp. Med. 196 (2002) 229-235
95. Olmo M.T., Rodriguez-Agudo D., Medina M.A., and Sanchez-Jimenez F. The pest regions containing C-termini of mammalian ornithine decarboxylase and histidine decarboxylase play different roles in protein degradation. Biochem. Biophys. Res. Commun. 257 (1999) 269-272
96. Tanaka S., Deai K., Konomi A., Takahashi K., Yamane H., Sugimoto Y., and Ichikawa A. Expression of L-histidine decarboxylase in granules of elicited mouse polymorphonuclear leukocytes. Eur. J. Immunol. 34 (2004) 1472-1482
97. Tanaka S., Fukui T., Yamamoto J., Shima Y., Kume T., Ohgo M., and Ichikawa A. Processing and activation of recombinant mouse mastocytoma histidine decarboxylase in the particulate fraction of Sf9 cells by porcine pancreatic elastase. Biochim. Biophys. Acta. 1253 (1995) 9-12
98. Fleming J.V., Sanchez-Jimenez F., Moya-Garcia A.A., Langlois M.R., and Wang T.C. Mapping of catalytically important residues in the rat L- histidine decarboxylase enzyme using bioinformatic and site-directed mutagenesis approaches. Biochem. J. 379 (2004) 253-261
99. Ichikawa A., Fukui T., Yamamoto J., Ohgoh M., Tanaka S., and Funakoshi S. De Novo synthesis and posttranslational processing of L-histidine decarboxylase in mice. Methods Find Exp. Clin. Pharmacol. 17 Suppl. C (1995) 5-9
100. Safina F., Tanaka S., Inagaki M., Tsuboi K., Sugimoto Y., and Ichikawa A. Expression of L-histidine decarboxylase in mouse male germ cells. J. Biol. Chem. 277 (2002) 14211-14215
101. Christen P., and Mehta P.K. From cofactor to enzymes. The molecular evolution of pyridoxal-5′-phosphate-dependent enzymes. Chem. Rec. 1 (2001) 436-447
102. Jansonius J.N. Structure, evolution and action of vitamin B6-dependent enzymes. Curr. Opin. Struct. Biol. 8 (1998) 759-769
103. Sandmeier E., Hale T.I., and Christen P. Multiple evolutionary origin of pyridoxal-5′-phosphate-dependent amino acid decarboxylases. Eur. J. Biochem. 221 (1994) 997-1002
104. Hayashi H. Pyridoxal enzymes: Mechanistic diversity and uniformity. J. Biochem. (Tokyo) 118 (1995) 463-473
105. Momany C., Ghosh R., and Hackert M.L. Structural motifs for pyridoxal-5′-phosphate binding in decarboxylases: An analysis based on the crystal structure of the Lactobacillus 30a ornithine decarboxylase. Protein Sci. 5 (1995) 849-854
106. Qu K., Martin D.L., and Lawrence C.E. Motifs and structural fold of the cofactor binding site of human glutamate decarboxylase. Protein Sci. 7 (1998) 1092-1105
107. Olmo M.T., Sanchez-Jimenez F., Medina M.A., and Hayashi H. Spectroscopic analysis of recombinant rat histidine decarboxylase. J. Biochem. (Tokyo) 132 (2002) 433-439
108. Capitani G., Tramonti A., Bossa F., Grutter M.G., and De Biase D. The critical structural role of a highly conserved histidine residue in group II amino acid decarboxylases. FEBS Lett. 554 (2003) 41-44
109. Burkhard P., Dominici P., Borri-Voltattorni C., Jansonius J.N., and Malashkevich V.N. Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase. Nat. Struct. Biol. 8 (2001) 963-967
110. Rodriguez-Caso C., Rodriguez-Agudo D., Moya-Garcia A.A., Fajardo I., Medina M.A., Subramaniam V., and Sanchez-Jimenez F. Local changes in the catalytic site of mammalian histidine decarboxylase can affect its global conformation and stability. Eur. J. Biochem. 270 (2003) 4376-4387
111. Moya-Garcia A.A., Medina M.A., and Sanchez-Jimenez F. Mammalian histidine decarboxylase: From structure to function. Bioessays 27 (2005) 57-63
112. Torrent A., Moreno-Delgado D., Gomez-Ramirez J., Rodriguez-Agudo D., Rodriguez-Caso C., Sanchez-Jimenez F., Blanco I., and Ortiz J. H3 autoreceptors modulate histamine synthesis through calcium/calmodulin- and cAMP-dependent protein kinase pathways. Mol. Pharmacol. 67 (2005) 195-203
113. Ishii S., Hayashi H., Okamoto A., and Kagamiyama H. Aromatic L-amino acid decarboxylase: Conformational change in the flexible region around Arg334 is required during the transaldimination process. Protein Sci. 7 (1998) 1802-1810
114. Kollonitsch J., Perkins L.M., Patchett A.A., Doldouras G.A., Marburg S., Duggan D.E., Maycock A.L., and Aster S.D. Selective inhibitors of biosynthesis of aminergic neurotransmitters. Nature 274 (1978) 906-908
115. Kubota H., Hayashi H., Watanabe T., Taguchi Y., and Wada H. Mechanism of inactivation of mammalian L-histidine decarboxylase by (S)-alpha-fluoromethylhistidine. Biochem. Pharmacol. 33 (1984) 983-990
116. Hammar L., Henningsson S., Henningsson A.C., Appelgren L.E., Tjalve H., and Kollonitsch J. Autoradiography of 3H-alpha-fluoromethyl histidine in mice: Correlation with the kidney histidine decarboxylase activity. Pharmacol. Toxicol. 67 (1990) 61-68
117. Onodera K., Yamatodani A., and Watanabe T. Effect of alpha-fluoromethylhistidine on brain histamine and noradrenaline in muricidal rats. Methods Find Exp. Clin. Pharmacol. 15 (1993) 423-427
118. Poulin R., Lu L., Ackermann B., Bey P., and Pegg A.E. Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine. Characterization of sequences at the inhibitor and coenzyme binding sites. J. Biol. Chem. 267 (1992) 150-158
119. Gallagher T., Snell E.E., and Hackert M.L. Pyruvoyl-dependent histidine decarboxylase. Active site structure and mechanistic analysis. J. Biol. Chem. 264 (1989) 12737-12743
120. Lindstrom E., Andersson K., Chen D., Monstein H.J., Boketoft A., and Hakanson R. alpha-Fluoromethylhistidine elevates histidine decarboxylase mRNA and chromogranin A mRNA levels in rat oxyntic mucosa. Inflamm. Res. 46 Suppl. 1 (1997) S107-S108
121. Maycock A.L., Aster S.D., and Patchett A.A. Inactivation of 3-(3,4-dihydroxyphenyl)alanine decarboxylase by 2-(fluoromethyl)-3-(3,4-dihydroxyphenyl)alanine. Biochemistry 19 (1980) 709-718
122. Watanabe T., Yamatodani A., Maeyama K., and Wada H. Pharmacology of alpha-fluoromethylhistidine, a specific inhibitor of histidine decarboxylase. Trends Pharmacol. Sci. 11 (1990) 363-367
123. Hayashi H., Tanase S., and Snell E.E. Pyridoxal 5′-phosphate-dependent histidine decarboxylase. Inactivation by alpha-fluoromethylhistidine and comparative sequences at the inhibitor- and coenzyme-binding sites. J. Biol. Chem. 261 (1986) 11003-11009
124. Bhattacharjee M.K., and Snell E.E. Pyridoxal 5′-phosphate-dependent histidine decarboxylase. Mechanism of inactivation by alpha-fluoromethylhistidine. J. Biol. Chem. 265 (1990) 6664-6668
125. Bartholeyns J., and Bouclier M. Involvement of histamine in growth of mouse and rat tumors. Antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase. Cancer Res. 44 (1984) 639-645
126. Garcia-Caballero M., Neugebauer E., Campos R., Nunez de Castro I., and Vara-Thorbeck C. Increased histidine decarboxylase (HDC) activity in human colorectal cancer: Results of a study on ten patients. Agents Actions 23 (1988) 357-360
127. Masini E., Fabbroni V., Giannini L., Vannacci A., Messerini L., Perna F., Cortesini C., and Cianchi F. Histamine and histidine decarboxylase up-regulation in colorectal cancer: Correlation with tumor stage. Inflamm. Res. 54 Suppl. 1 (2005) S80-S81
128. Hegyesi H., Somlai B., Varga V.L., Toth G., Kovacs P., Molnar E.L., Laszlo V., Karpati S., Rivera E., and Falus A. Suppression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotides. J. Invest. Dermatol. 117 (2001) 151-153
129. Pos Z., Safrany G., Muller K., Toth S., Falus A., and Hegyesi H. Phenotypic profiling of engineered mouse melanomas with manipulated histamine production identifies histamine H2 receptor and rho-C as histamine-regulated melanoma progression markers. Cancer Res. 65 (2005) 4458-4466
130. Sieja K., Stanosz S., von Mach-Szczypinski J., Olewniczak S., and Stanosz M. Concentration of histamine in serum and tissues of the primary ductal breast cancers in women. Breast 14 (2005) 236-241
131. Kolby L., Wangberg B., Ahlman H., Modlin I.M., Granerus G., Theodorsson E., and Nilsson O. Histidine decarboxylase expression and histamine metabolism in gastric oxyntic mucosa during hypergastrinemia and carcinoid tumor formation. Endocrinology 137 (1996) 4435-4442
132. Boer K., Darvas Z., Bosze S., Schwelberger H., Baki M., Belai F., Pal Z., and Falus A. Histamine metabolism and CD8(+) T cell infiltration in colon adenomas. Inflamm. Res. 53 Suppl. 1 (2004) S83-S84
133. Rajendra S., Mulcahy H., Patchett S., and Kumar P. The effect of H2 antagonists on proliferation and apoptosis in human colorectal cancer cell lines. Dig. Dis. Sci. 49 (2004) 1634-1640
134. Natori T., Sata M., Nagai R., and Makuuchi M. Cimetidine inhibits angiogenesis and suppresses tumor growth. Biomed. Pharmacother. 59 (2005) 56-60
135. Tomita K., Izumi K., and Okabe S. Roxatidine- and cimetidine-induced angiogenesis inhibition suppresses growth of colon cancer implants in syngeneic mice. J. Pharmacol. Sci. 93 (2003) 321-330
136. Diks S.H., Hardwick J.C., Diab R.M., van Santen M.M., Versteeg H.H., van Deventer S.J., Richel D.J., and Peppelenbosch M.P. Activation of the canonical beta-catenin pathway by histamine. J. Biol. Chem. 278 (2003) 52491-52496
137. Haak-Frendscho M., Darvas Z., Hegyesi H., Karpati S., Hoffman R.L., Laszlo V., Bencsath M., Szalai C., Furesz J., and Timar J. Histidine decarboxylase expression in human melanoma. J. Invest. Dermatol. 115 (2000) 345-352
138. Hegyesi H., Horvath B., Pallinger E., Pos Z., Molnar V., and Falus A. Histamine elevates the expression of Ets-1, a protooncogen in human melanoma cell lines through H2 receptor. FEBS Lett. 579 (2005) 2475-2479
139. Garcia-Caballero M., Neugebauer E., Rodriguez F., Nunez de Castro I., and Vara-Thorbeck C. Histamine synthesis and content in benign and malignant breast tumours. Its effects on other host tissues. Surg. Oncol. 3 (1994) 167-173
140. Cricco G.P., Davio C.A., Martin G., Engel N., Fitzsimons C.P., Bergoc R.M., and Rivera E.S. Histamine as an autocrine growth factor in experimental mammary carcinomas. Agents Actions 43 (1994) 17-20
141. Graff L., Frungieri M., Zanner R., Pohlinger A., Prinz C., and Gratzl M. Expression of histidine decarboxylase and synthesis of histamine by human small cell lung carcinoma. Am. J. Pathol. 160 (2002) 1561-1565
142. Tetlow L.C., and Woolley D.E. Histamine stimulates the proliferation of human articular chondrocytes in vitro and is expressed by chondrocytes in osteoarthritic cartilage. Ann. Rheum. Dis. 62 (2003) 991-994
143. Radvany Z., Darvas Z., Kerekes K., Prechl J., Szalai C., Pallinger E., Valeria L., Varga V.L., Sandor M., and Erdei A. H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells. Semin. Cancer Biol. 10 (2000) 41-45
144. Folkman J. Tumor angiogenesis: A possible control point in tumor growth. Ann. Intern. Med. 82 (1975) 96-100
145. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer 2 (2002) 795-803
146. McMahon G. VEGF receptor signaling in tumor angiogenesis. Oncologist 5 Suppl. 1 (2000) 3-10
147. Ribatti D., Crivellato E., Roccaro A.M., Ria R., and Vacca A. Mast cell contribution to angiogenesis related to tumour progression. Clin. Exp. Allergy 34 (2004) 1660-1664
148. Iamaroon A., Pongsiriwet S., Jittidecharaks S., Pattanaporn K., Prapayasatok S., and Wanachantararak S. Increase of mast cells and tumour angiogenesis in oral squamous cell carcinoma. J. Oral Pathol. Med. 32 (2003) 195-199
149. Yano H., Kinuta M., Tateishi H., Nakano Y., Matsui S., Monden T., Okamura J., Sakai M., and Okamoto S. Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis. Gastric Cancer 2 (1999) 26-32
150. Sorbo J., Jakobsson A., and Norrby K. Mast-cell histamine is angiogenic through receptors for histamine1 and histamine2. Int. J. Exp. Pathol. 75 (1994) 43-50
151. Ghosh A.K., Hirasawa N., Ohtsu H., Watanabe T., and Ohuchi K. Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J. Exp. Med. 195 (2002) 973-982
152. Caruso C., Lio D., Cavallone L., and Franceschi C. Aging, longevity, inflammation, and cancer. Ann. N. Y. Acad. Sci. 1028 (2004) 1-13
153. Balkwill F., Charles K.A., and Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7 (2005) 211-217
154. Houghton J., Stoicov C., Nomura S., Rogers A.B., Carlson J., Li H., Cai X., Fox J.G., Goldenring J.R., and Wang T.C. Gastric cancer originating from bone marrow-derived cells. Science. 306 (2004) 1568-1571
155. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Urieli-Shoval S., Galun E., and Ben-Neriah Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (2004) 461-466
156. Greten F.R., Eckmann L., Greten T.F., Park J.M., Li Z.W., Egan L.J., Kagnoff M.F., and Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118 (2004) 285-296
157. MacGlashan Jr. D. Histamine: A mediator of inflammation. J. Allergy Clin. Immunol. 112 (2003) S53-S59
158. Falus A. Interleukin-6 biosynthesis is increased by histamine in human B-cell and glioblastoma cell lines. Immunology 78 (1993) 193-196
159. Delneste Y., Lassalle P., Jeannin P., Joseph M., Tonnel A.B., and Gosset P. Histamine induces IL-6 production by human endothelial cells. Clin. Exp. Immunol. 98 (1994) 344-349
160. Mor S., Nagler A., Barak V., Handzel Z.T., Geller-Bernstein C., and Fabian I. Histamine enhances granulocyte-macrophage colony-stimulating factor and interleukin-6 production by human peripheral blood mononuclear cells. J. Leukoc. Biol. 58 (1995) 445-450
161. Takamatsu S., and Nakano K. Regulation of interleukin-6, and macrophage colony-stimulating factor mRNA levels by histamine in stromal cell line (MC3T3-G2/PA6). Inflamm. Res. 47 (1998) 221-226
162. Horvath B.V., Falus A., Toth S., Szalai C., Lazar-Molnar E., Holub M.C., Buzas E., Nagy A., and Fulop A.K. Inverse regulation of interleukin-6 (IL-6) and IL-6 receptor in histamine deficient histidine decarboxylase-knock-out mice. Immunol. Lett. 80 (2002) 151-154
163. Klausz G., Buzas E., Scharek P., Tiszlavicz L., Gyulai Z., Fulop A.K., Falus A., and Mandi Y. Effects of Helicobacter pylori infection on gastric inflammation and local cytokine production in histamine-deficient (histidine decarboxylase knock-out) mice. Immunol. Lett. 94 (2004) 223-228
164. Chen D., Zhao C.M., Andersson K., Sundler F., and Hakanson R. Ultrastructure of enterochromaffin-like cells in rat stomach: Effects of alpha-fluoromethylhistidine-evoked histamine depletion and hypergastrinemia. Cell Tissue Res. 283 (1996) 469-478
165. Andersson K., Zhao C.M., Chen D., Sundler F., and Hakanson R. Effect of alpha-fluoromethylhistidine-evoked histamine depletion on ultrastructure of endocrine cells in acid-producing mucosa of stomach in mouse, rat and hamster. Cell Tissue Res. 286 (1996) 375-384
166. Friis-Hansen L., Sundler F., Li Y., Gillespie P.J., Saunders T.L., Greenson J.K., Owyang C., Rehfeld J.F., and Samuelson L.C. Impaired gastric acid secretion in gastrin-deficient mice. Am. J. Physiol. 274 (1998) G561-G568
167. Chen D., Zhao C.M., Al-Haider W., Hakanson R., Rehfeld J.F., and Kopin A.S. Differentiation of gastric ECL cells is altered in CCK (2) receptor-deficient mice. Gastroenterology 123 (2002) 577-585
168. Fossmark R., Martinsen T.C., Bakkelund K.E., Kawase S., and Waldum H.L. ECL-cell derived gastric cancer in male cotton rats dosed with the H2-blocker loxtidine. Cancer Res. 64 (2004) 3687-3693
169. Kobayashi T., Tonai S., Ishihara Y., Koga R., Okabe S., and Watanabe T. Abnormal functional and morphological regulation of the gastric mucosa in histamine H2 receptor-deficient mice. J. Clin. Invest. 105 (2000) 1741-1749
170. Nakamura E., Kataoka T., Furutani K., Jimbo K., Aihara T., Tanaka S., Ichikawa A., Ohtsu H., and Okabe S. Lack of histamine alters gastric mucosal morphology: Comparison of histidine decarboxylase-deficient and mast cell-deficient mice. Am. J. Physiol. Gastrointest. Liver Physiol. 287 (2004) G1053-G1061
171. Hunyady B., Zolyomi A., Czimmer J., Mozsik G., Kozicz T., Buzas E., Tanaka S., Ichikawa A., Nagy A., and Palkovits M. Expanded parietal cell pool in transgenic mice unable to synthesize histamine. Scand. J. Gastroenterol. 38 (2003) 133-140
172. Wang T.C., Dangler C.A., Chen D., Goldenring J.R., Koh T., Raychowdhury R., Coffey R.J., Ito S., Varro A., and Dockray G.J. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 118 (2000) 36-47